Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 274

1.

[Therapy of alcoholic and non-alcoholic fatty liver].

Stremmel W, Blechacz B, Herrmann T, Rost D, Mueller S.

Internist (Berl). 2001 Dec;42(12):1641-2, 1645-50. Review. German. No abstract available.

PMID:
11793603
2.

Pharmacologic therapy of non-alcoholic steatohepatitis.

Ratziu V, Zelber-Sagi S.

Clin Liver Dis. 2009 Nov;13(4):667-88. doi: 10.1016/j.cld.2009.07.001.

PMID:
19818312
3.

Review article: Drug therapy for non-alcoholic fatty liver disease.

Comar KM, Sterling RK.

Aliment Pharmacol Ther. 2006 Jan 15;23(2):207-15. Review.

4.

[Non-alcoholic steatohepatitis].

Alvarez-Martínez H, Pérez-Campos E.

Rev Gastroenterol Mex. 2002 Apr-Jun;67(2):118-25. Review. Spanish.

PMID:
12214335
5.

[Non-alcoholic steatohepatitis].

Rakov AL, Gorbakov VV, Vecherinina OO.

Voen Med Zh. 2006 Jul;327(7):33-9. Russian. No abstract available.

PMID:
16977879
6.

Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment.

Bugianesi E, Marzocchi R, Villanova N, Marchesini G.

Best Pract Res Clin Gastroenterol. 2004 Dec;18(6):1105-16. Review.

PMID:
15561641
7.

Non-alcoholic steato-hepatitis.

Chawla Y, Amrapurkar D.

Trop Gastroenterol. 2002 Oct-Dec;23(4):186-8. No abstract available.

PMID:
12833707
8.

[Alcoholic and non-alcoholic steatohepatitis].

Dufour JF, Oneta CM.

Ther Umsch. 2004 Aug;61(8):505-12. Review. German.

PMID:
15457967
9.

Non-alcoholic fatty liver: a common manifestation of a metabolic disorder.

Malnick SD, Beergabel M, Knobler H.

QJM. 2003 Oct;96(10):699-709. Review. No abstract available.

PMID:
14500857
10.

[Non-alcoholic fatty liver--life of overindulgence with fatty liver].

Füessl HS.

MMW Fortschr Med. 2005 Jun 23;147(25):4-6, 8. German. No abstract available.

PMID:
16038330
11.

[Fatty liver: frequent and not completely harmless].

Lang C, Georgi A, Gubler C.

Praxis (Bern 1994). 2013 Sep 4;102(18):1089-101. doi: 10.1024/1661-8157/a001420. German. No abstract available.

12.

Therapy for nonalcoholic fatty liver disease.

Moseley RH.

J Clin Gastroenterol. 2008 Apr;42(4):332-5. doi: 10.1097/MCG.0b013e31815e4079. No abstract available.

PMID:
18277910
13.

[Fatty liver].

Andrade RJ, García-Escaño MD.

Med Clin (Barc). 2000 Apr 22;114(15):574-6. Spanish. No abstract available.

PMID:
10846676
14.

Alcoholic and nonalcoholic forms of fatty liver disease.

Forgione A, Miele L, Cefalo C, Gasbarrini G, Grieco A.

Minerva Gastroenterol Dietol. 2007 Mar;53(1):83-100. Review.

PMID:
17415346
15.

[Treatment of non-alcoholic steatohepatitis].

Fehér J, Hagymási K.

Orv Hetil. 2004 Mar 21;145(12):631-4. Review. Hungarian. No abstract available.

PMID:
15119118
16.

Nonalcoholic fatty liver disease.

Paredes AH, Torres DM, Harrison SA.

Clin Liver Dis. 2012 May;16(2):397-419. doi: 10.1016/j.cld.2012.03.005. Review.

PMID:
22541706
17.

Treatment of patients with non-alcoholic fatty liver disease: current views and perspectives.

Federico A, Trappoliere M, Loguercio C.

Dig Liver Dis. 2006 Nov;38(11):789-801. Epub 2006 Jun 5. Review.

PMID:
16750661
18.

[Fatty liver and raised gamma-GT: it can happen to abstainers, too].

Bischoff A.

MMW Fortschr Med. 2002 Feb 14;144(7):18. German. No abstract available.

PMID:
11887726
19.

[Nonalcoholic steatohepatitis: epidemiology, diagnosis and treatment].

Tilg H.

Dtsch Med Wochenschr. 2001 Apr 20;126(16):467-71. Review. German. No abstract available.

PMID:
11360453
20.

[Use of ursodeoxycholic acid combined with silymarin in the treatment of chronic ethyl-toxic hepatopathy].

Bettini R, Gorini M.

Clin Ter. 2002 Sep-Oct;153(5):305-7. Italian.

PMID:
12510413

Supplemental Content

Support Center